Article
Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity.
Pharmacogenetics - 1 Nov 2000
Pirmohamed M, Alfirevic A, Vilar J, Stalford A, Wilkins E G, Sim E, Park B K
Abstract excerpt
The use of co-trimoxazole in HIV-positive patients has been associated with a high frequency (40-80%) of hypersensitivity reactions. This has been attributed to the bioactivation of the sulphonamide component, sulphamethoxazole (SMX), to its toxic hydroxylamine and nitroso metabolites. The aim of this study was to determine whether functionally significant polymorphisms in the genes coding for enzymes involved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
